. Second, we labeled tubulin (that belongs to slow component a, traveling down the axon at the axon anterogradely. Both moving profiles showed significant effect due to diffusion, but their transporting speed of 0.2-1 mm/day) and creatine kinase (that be- speed was much slower than that of axoplasmic vesiwas applied to the bath and injection solution at the concentration of 20 g/ml, its transport was significantly cles. As shown in Figures 2A and 2B and Table 1, both blocked (estimated transporting speed was 60.9 Ϯ 24.1 proteins were transported at similar speeds and time m/hr [n ϭ 5], *P Ͻ 0.01, t test) ( Figures 3A and 3E ). course at first. The transport speed of tubulin within 20
This blockage was not specific to tubulin transport, and min after injection was 149.2 Ϯ 43.6 m/hr (n ϭ 8) and other cytosolic proteins examined were also stopped that of creatine kinase was 151.7 Ϯ 49.6 m/hr (n ϭ 9).
by nocodazole treatment (see below for details). But But long-term (1 or 2 hr) measurement revealed that when nocodazole was washed out, as shown in Figures the moving speed decreased time-dependently, and the 3B and 3E, axon regained its ability to transport tubulin speed of creatine kinase (1 hr, 84.9 Ϯ 11.6 m/hr [n ϭ (estimated transporting speed was 140.7 Ϯ 32.1 m/hr 5]; 2 hr, 98.2 Ϯ 16.9 m/hr [n ϭ 5]), was faster than that [n ϭ 5]), confirming that the drug blocked tubulin transof tubulin (1 hr, 34.2 Ϯ 14.7 m/hr [n ϭ 4]; 2 hr, 38.7 Ϯ port reversibly, thus functionally. We conclude that in-16.9 m/hr [n ϭ 4]) (Table 1) ; the estimated transporting tact microtubule is necessary for this kind of transport. speed of creatine kinase at 1 or 2 hr from injection was We further examined whether this tubulin transport about 2.5 times faster than that of tubulin, both of which is dependent on the actomyosin system. We applied were compatible within the range of slow axonal transmembrane-permeable actin-destabilizing agent, cytoport rate. This time-dependent decrease in transporting chalasin D, at the concentration of 2 M, to a squid speed was not due to any deteriorating effect on slow giant axon in the same way as mentioned above. This transporting cargoes during observation in our system time, even in the presence of a higher dosage of actin because there was no apparent difference in transdepolymerizing agent than the usual working concentraporting profiles even after the preparation had been tion, the moving speed of transporting profile was not sitting for an hour. When we injected tubulin immediately significantly different from that of control specimen (estiafter dissection, the gravity center of each fitted curve mated transporting speed was 99.9 Ϯ 34.9 m/hr [n ϭ 5]) traveled for 121.3 Ϯ 17.6 m (n ϭ 4) and 194.4 Ϯ 24.5 m (Figures 3C and 3E ). Then, we applied 2-,3-butanedione (n ϭ 4) from injection point at 1 hr and 2 hr postinjection, monoxime (BDM), another membrane-permeable drug, respectively. This transporting distance measured later which is known to block myosin ATPase but not to affect in the experimental process recapitulated the one of the kinesin ATPase activity (Higuchi, 1989; Bi et al., 1997) initial trial. For example, even when the preparations in the injection (by mixing saturated aqueous BDM soluremained in standard internal solution for more than an tion) or bath solutions (at the concentration of 50 mM). hour after dissection, the gravity center of each fitted Again, both treatments did not interfere with tubulin curve for injected tubulin profile traveled for 122.0 Ϯ movement significantly (estimated transporting speed 36.3 m (n ϭ 4) and 189.6 Ϯ 46.6 m (n ϭ 4) from was 132. between the initial and later (more than 1 hr after injec-1996), we consider that the slow axonal transport might tion) time points might reflect any different mechanism share its mechanism with that of the fast axonal transof transport, we repeated the same kind of pharmacoport, which is dependent on microtubule-based motors.
logical experiments with creatine kinase using the long But there is also another possibility that the actomyosin time points (Table 2) . We measured the transporting system also plays a role in slow axonal transport. To distance of creatine kinase from injection point after 1, test these possibilities, we performed pharmacological 2, and 3 hr postinjection. During 1 and 2 hr postinjection, experiments that disturb above two cytoskeletal syswe applied nocodazole (at the concentration of 40 g/ tems separately, and calculated the speed of the gravity ml), or cytochalasin D (at the concentration of 2 M) to center of transporting profiles in the same way as menthe bath. As shown in Table 2 , the first transporting tioned above. As shown in Figure 2A, Figures 8C and 8D) .
as a population in vivo was much slower. Also, retroFurther, calculated diffusion time of both proteins based on FCS measurement revealed significant prolonspectively, our results are compatible with the previous and there was no significant difference between tubulin AMP-PNP is a nonhydrolyzable analog of ATP with a broad spectrum, the effect on motility of this drug and creatine kinase at the first 20 min measurement. But, as suggested from the FCS data (see discussion against kinesin is very strong and drastic, compared to other ATPase motor molecules, for example myosin. below), the interaction between cargoes and tracks is presumed to be transient and the molecules off the The basis of this effect lies in the fact that AMP-PNP stops the ATPase cycle of kinesin in the state of rigor transport easily diffuse into axoplasm. Observation by CLSM could not detect these diffusing molecules, thus binding with microtubule tracks (Hackney, 1996) . This rigor binding was key and unique in nature for purificathe average transporting speed as a whole decreases in a time-dependent manner. When we observe the samtion of kinesin from other motors and ATPase (Vale et al., 1985) . In marked contrast with this, in the case of ples for a long time (more than 1 hr (Table 1) ), the transporting speed seems to converge to the value, which is myosin, AMP-PNP stops the cycle of ATPase at the stage of weak binding state with tracks, not in the rigor compatible with the data of metabolic labeling studies. Strictly speaking, we cannot measure the transporting binding state. Thus, the inhibition by AMP-PNP on motility supported by myosin is rather weak. As far as we speed in an equilibrated state in our system (because the observation time is limited), but we believe that the know, this strong inhibitory action of AMP-PNP on motility, even in low concentration, is unique to kinesin or converged value observed later well reflects the average speed in vivo. These figures are well consistent with the kinesin superfamily proteins. This is why we consider that the inhibitory effect of AMP-PNP is directly relevant preceding metabolic labeling data. In addition, another protein, actin, which belongs to slow component b, travto kinesin function. Our next experiment using functional blocking antibody against kinesin also reinforced this eled down the axon at the speed of 72.92 m/hr (n ϭ 2, the first 2 hr measurement) and its moving profile idea. We used Fab fragment of H2 antibody to avoid possible artificial effect, and confirmed that this treatwas similar to that of creatine kinase (data not shown). Collectively, these results remind us of the classical ment did not perturb cytoskeletal architecture of extruded axoplasm by electron microscopy. The fact that classification of mammalian axonal transport, which groups the transporting cargoes as fast, slow compoanti-kinesin heavy chain antibody could block the tubulin transport significantly further strengthened the nent a, and slow component b. We believe that the basic mechanism of both fast and slow axonal transport is idea that kinesin is a key molecule for slow axonal transport. As several independent laboratories, including shared by various animals, including squids, rats, or humans. As in the case of the discovery of kinesin as a ours, reported previously, the majority of tubulin molecules is transported in an unpolymerized form in axons fast axonal transport motor, we could learn much about the slow axonal transport mechanism from the squid (Okabe and Hirokawa, 1988 that we could surely observe the slow transporting molecules in vivo (Figures 8A-8D) . Moreover, measured diffuFollowing dose-dependent or reversible blockage of tubulin or creatine kinase transport by AMP-PNP also sion time of both tubulin and creatine kinase was significantly larger in the distal region of the injection point, strongly suggested that the participating motors are kinesin or kinesin superfamily proteins. Both initial rates thus implicating association between transporting proteins and the cytoskeleton, presumably microtubules of tubulin transport and those of creatine kinase at later time points responded in the same way to the pharmaco-( Figures 8E and 8F) . We consider that this interaction might be transient and fairly weak, and we imagine that logical treatments, demonstrating that both initial and later rates are relevant for the analysis of slow axonal the population of proteins on active transport might be small in population, compared to the number of proteins transport, and dependent on kinesin function. Though 1998; Hirokawa, 1998). But using this system, we believe squid, and cleaned to remove fin nerves as much as possible. During dissection, the injured axons, which showed "white spot" in axothat we will be able to clarify the molecular mechanism plasm, were discarded. Dissected axons were ligated with both ends of cytoplasmic protein transport in a cell, one of the and enclosed into a glass chamber, with a cantilevered coverslip most generalized problems in cell biology. Kinjo, 1998a Kinjo, , 1998b . FCS measurement was performed using a fluorescence correlation measurement system (Conto a manipulator (MM-3, Narishige, Tokyo, Japan), then injected into giant axons from lateral side with pressure. When we injected foCor, Carl Zeiss Jena GmbH, Jena, Germany) with a ϫ40 waterimmersion objective (C-apochromat, 1.2 N.A.) at room temperature. samples into giant axons, we controlled the amount of samples to be injected within 160 pl, because overload injection often impaired Excitation laser wavelength and power were 488 nm and 10 W, respectively. The squid giant axon on a coverglass was set on the the transporting profiles of the specimen. In contrast, when we injected samples into extruded axoplasm, we injected up to 400 pl objective within a small chamber to prevent solvent evaporation during measurement ( 
